Xue, Lei
Yi, Yan
Xu, Qianwen
Wang, Li
Yang, Xiaohui
Zhang, Yongjing
Hua, Xuefei
Chai, Xiaoshan
Yang, Junjie
Chen, Yaxin
Tao, Guangshi
Hu, Biliang
Wang, Xingbing
Article History
Received: 4 October 2020
Accepted: 1 July 2021
First Online: 14 September 2021
Conflict of interest
: All IP rights surrounding the technology in designing and engineering the CART cells used in this study belong to Celledit and Siweikang Therapeutics. B.H. is the founder of Celledit and Siweikang Therapeutics. The other authors do not have any financial interest to disclose.